Review: Reactivation of tuberculosis by tumor necrosis factor neutralization
Muazzam Jacobs1, Arina Samarina2, Sergei Grivennikov2,3, Tania Botha4, Nasiema Allie1, Cecile Fremond2, Dieudonnée Togbe2, Virginie Vasseur2, Stephanie Rose2, Francois Erard2, Analbery Monteiro2, Sergei Nedospasov3,5, Valerie Quesniaux2, Bernhard Ryffel1,2
European Cytokine Network, Vol.18, No.1, pp. 1-9, 2007, DOI:10.1684/ecn.2007.0083
Abstract Tumor necrosis factor (TNF) is required in the control of infection with Mycobacterium tuberculosis
(Mtb), the causative agent of tuberculosis. TNF is essential and non-redundant for forming microbiocidal
granulomas, and cannot be replaced by other members of the TNF family. We established a model of latent Mtb
infection in mice, allowing investigation of the reactivation of latent Mtb as observed in patients receiving
TNF-neutralizing therapy used in rheumatoid arthritis and Crohn’s disease. Antibody neutralization of TNF is
able to reactivate clinically silent Mtb infection. Using mutant mice expressing solely membrane, but not soluble
TNF, we demonstrated More >